Cancer treatment

Details for Australian Patent Application No. 2012100727 (hide)

Owner Pfizer Inc.

Inventors Huang, Bo; Marshall, Margaret Ann

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012100727

Parent 2010308030

Filing date 22 May 2012

Opi date 21 June 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

7 June 2012 Innovation Patent Application Filed

21 June 2012 Innovation Patent Open to Public Inspection

  Published as AU-A-2012100727

21 June 2012 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012100728-Improved Clamping device

2012100726-Uniquly devised online, and group classes, educational finishing school and comprehensive program to develop and deliver grooming, deportment, modelling, modern day etiquitte, self confidence, personal profile, presenting , life skills and public speaking